FIU News3d
Promising new drug candidate for Alzheimer’s
Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...
Pharmabiz5h
Health Canada authorizes Roche’s Vabysmo pre-filled syringe for three leading causes of vision loss
Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...
FDA Accepts Astellas Pharma's Revised SNDA For IZERVAY In Geographic Atrophy Treatment
Astellas Pharma Inc. (ALPMY, ALPMY) announced that the U.S. Food and Drug Administration accepted the revised supplemental New Drug ...
Monthly Prescribing Reference4d
Trial Results to Prompt BLA Resubmission for Intravitreal Formulation of Bevacizumab
ONS-5010 is an investigational ophthalmic formulation of bevacizumab, a vascular endothelial growth factor inhibitor, under development as an intravitreal injection.
Science Daily6d
Genetic risks for age-related macular degeneration
Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...
US veterans study helps identify genetic risks for age-related macular degeneration
Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, ...
Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge
Aging Population and Pipeline Launches Fuel Rapid Growth in Ophthalmic Pharma MarketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs Market Report 2025-2035" has been added to ...